Lutein
A familiar starting point. A wider world of research.
Follow lutein through source-linked records, connected to Vision ageing and Frailty. Explore the connections, then open the original evidence.
Explore the evidenceUnexpected company.
A selection of other objects mentioned in these records. Inspect the shared source to see the connection; a shared mention does not mean the same effect.
zeaxanthin
Inspect supporting records 8carotenoids
Inspect supporting records 7beta carotene
Inspect supporting records 3Frailty
Inspect supporting records 2vitamin a
Inspect supporting records 2zinc
Inspect supporting records 2More connections in this selection
fish oil
Inspect supporting records 1lycopene
Inspect supporting records 1mediterranean diet
Inspect supporting records 1omega 3
Inspect supporting records 1Omega-3 fatty acids
Inspect supporting records 1Oxidative stress
Inspect supporting records 1saffron
Inspect supporting records 1Sarcopenia
Inspect supporting records 1vitamin e
Inspect supporting records 1vitamin k
Inspect supporting records 1Where the research leads.
Published topic links attached to the selected records. Each dossier opens a wider field, including its own research ecosystem.
- Vision ageingRecords in this selection 22
- FrailtyRecords in this selection 2
- Mediterranean dietRecords in this selection 1
- Microbiome and dysbiosisRecords in this selection 1
Meet the wider research ecosystem.
Follow a connected field into its universities, funding and patent activity.
University, grant and patent activity in a topic dossier concerns that wider field; it is not a lutein-specific total.
Different records. Different questions.
This is the composition of the initial 24-record selection, not the entire collection. Open a group to inspect its supporting records. Publication types and existing automated evidence labels describe records, not their quality or conclusions. Unclassified records remain in “Other research records”.
The recent trail.
Recent sources in this selection: publication months for publications, registry update months for registrations.
- Trial registrations
Lutein, Zeaxathin, and Fish Oil Supplementation
Good questions to bring along.
What can I learn about lutein here?
See which permitted records mention this object, follow the topics and other objects connected through those records, and inspect the sources. Whole foods, preparations, extracts and isolated compounds keep separate identities.
Do these records establish a benefit?
A mention is a starting point for discovery. Open each original source to assess the study design, population, findings and limitations. A trial registration describes planned or registered work; it is not itself a result.
How can I compare related objects?
Open a connected object and compare the actual records, preparations and research settings. “Mentioned in the same record” explains a navigation link; it does not establish equivalence, composition or causality.
How complete is this picture?
This is the current eligible selection from the immortal.life index; use Show more records to continue browsing. Missing records or classifications do not prove that research is absent. Source permissions and corrections can change the selection.
Open the evidence.
Cornea-Penetrating Nanodrug Co-Delivering VEGF-Silencing siRNA and Lutein for Treating Age-Related Macular Degeneration.
Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study
Lutein, Zeaxathin, and Fish Oil Supplementation
Lutein: A natural defence combating age-related macular degeneration.
Interaction between Infection of Porphyromonas gingivalis, A Keystone Microbe of Oral Microbiome, and Serum Levels of Lutein/Zeaxanthin Is Associated with Risk for Age-related Macular Degeneration.
Evaluation of the macula pigment optical density by a psychophysical test in dry age-related macular degeneration.
Oral Antioxidant and Lutein/Zeaxanthin Supplements Slow Geographic Atrophy Progression to the Fovea in Age-Related Macular Degeneration.
Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut-Retina Axis in Patients with Neovascular Age-Related Macular Degeneration-A Randomized Clinical Trial.
The role of nutritional factors in transitioning between early, mid, and late stages of age-related macular degeneration: prospective longitudinal analysis.
Association of macular pigment optical density with plasma macular carotenoids levels and serum lipids in South Indian healthy volunteers and patients with early age-related macular degeneration.
LUTEIN BY SCLERAL IONTOPHORESIS IN PATIENTS WITH STAGE 3 AGE-RELATED MACULAR DEGENERATION (AMD)
Protection effect of lutein-loaded Pickering emulsion prepared via ultrasound-assisted Maillard reaction conjugates on dry age-related macular degeneration.
[Nutrition and age-related macular degeneration].
Macular Pigment Optical Density in First Degree Relatives of Age-Related Macular Degeneration Patients.
Fluorescence lifetime imaging ophthalmoscopy and the influence of oral lutein/zeaxanthin supplementation on macular pigment (FLOS) - A pilot study.
The value of pre-symptomatic genetic risk assessment for age-related macular degeneration: the Moran AMD Genetic Testing Assessment (MAGENTA) study-a study protocol for a randomized controlled trial.
Patterns of Dietary Blood Markers Are Related to Frailty Status in the FRAILOMIC Validation Phase.
Plasma lutein and zeaxanthin concentrations associated with musculoskeletal health and incident frailty in The Irish Longitudinal Study on Ageing (TILDA).
Effect of the Mediterranean Diet on Progression of Dry Form of Age-related Macular Degeneration.
Macular and Plasma Xanthophylls Are Higher in Age-related Macular Degeneration than in Normal Aging: Alabama Study on Early Age-related Macular Degeneration 2 Baseline.
The Effect of Dietary Supplementations on Delaying the Progression of Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis.
Dietary vitamins, carotenoids and their sources in relation to age-related macular degeneration risk in China: a population-based case-control study.
Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28.
Challenges in Age-Related Macular Degeneration: From Risk Factors to Novel Diagnostics and Prevention Strategies.
About this collection: scope and limitations
Nutrient or compound · Compound identity, formulation and the studied outcome matter. A record about a related substance, a product or a mechanism does not automatically apply to this identity.
Questions to check in the original studies
- Which compound and formulation does the source identify?
- Which population and outcome were studied?
- Is an observation about a measured outcome being distinguished from a claim about ageing or lifespan?
What the displayed selection contains
21 research metadata records and 3 trial registrations were returned in the initial selection. More records can be loaded above. This is not a complete worldwide evidence review. These counts do not measure benefit, safety or evidence certainty.
Interpretation remains unassessed
Open the original sources to assess study design, findings and applicability. A trial registration is not a result; a metadata mention is not a scientific conclusion. Missing matches do not establish that research is absent.
Index snapshot: . This is the index projection timestamp, not the date of a discovery or expert review.
Cite this research-navigation view
immortal.life. lutein: research mentions. https://www.immortal.life/explore/lutein. Projection snapshot: 2026-10-15T16:05:00.336Z.
Include your access date. This citation identifies an automated navigation view, not a clinical conclusion. The live selection can change with corrections and source permissions.
Matching, coverage and vocabulary provenance
This automated index uses permitted minimal bibliographic metadata and checks current source and record eligibility. Literal title or controlled-term matches are discovery relationships, not scientific findings. Retained metadata coverage is bounded; historical completeness of external sources is not certified.
Foods, preparations, extracts and compounds retain distinct identities. Ambiguous labels require a choice. Source AI processing, model training and raw redistribution are disabled for this search.
Vocabulary attribution: FoodOn contributors, CC BY 4.0, filtered own-namespace labels/IDs and references; courtesy of the U.S. National Library of Medicine, 2026 MeSH vocabulary terms, filtered labels/entry terms; USDA FoodData Central, Foundation Foods April 2026, CC0, filtered identifiers/descriptions. No source endorsement. Navigation spelling/plural changes are separately attributed.
